United States · Funded startup

Who invested in Zenas BioPharma

3 rounds we have observed, with the 16 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechPharma

Raised 8 months ago

Funding summaryUpdated 26 Oct 2026

$420Mraised across 3 rounds since 2024, from 3 sources

$200MSeries C$120MRound$100MRound
Latest round
Round, $100MMar 2026
Biggest round
$200MSeries C · May 2024
Investors
16 (4 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20252026
$200MSeries C$120MRound$100MRound
First round
Series C, $200M
May 2024
Biggest round
$200M
Series C · May 2024
Usual gap between rounds
17 months
the median of 2

The rounds

  1. Mar 2026
  2. Oct 2025
  3. May 2024

Founders and team

From Zenas BioPharma's own website and the SEC filings it signed: 1 founder, 11 on the team.

Lonnie MoulderFounder, CEO & Chairman
  • Joe FarmerPresident and Chief Operating Officer
  • Caroline ChevalierChief Administrative Officer
  • Christy OligerBoard of Directors
  • Jake Jacob NunnBoard of Directors
  • James Patrick BoylanBoard of Directors
  • Jennifer Jacob FoxExecutive Officeri
  • Joseph O. FarmerExecutive Officeri
  • Leon O. MoulderExecutive Officer, Directori
  • Patricia Jacob AllenBoard of Directors
  • Patrick Gerald EnrightBoard of Directors
  • Tanya Z. FischerExecutive Officeri

On the board, as filediHongbo O. LuJohn Jacob OrloffTim Jacob XiaoTomas O. Kiselak

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

New Enterprise AssociatesVC firm3rounds, led 1
Norwest Venture PartnersVC firm3rounds, led 1
Wellington ManagementVC firm3rounds
Vivo CapitalPrivate equity3rounds
SR OneCorporate VC2rounds, led 1
Delos CapitalPrivate equity1round, led 1
Perceptive AdvisorsAsset manager1round
Longitude CapitalVC firm1round
Rock Springs CapitalHedge fund1round
ArrowMark PartnersPrivate equity1round
FairmountGrowth equity1round
Enavate SciencesVC firm1round
Quan Venture FundGrowth equity1round
Superstring CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Zenas BioPharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Tellus BioVenturesVC firmPer its own site

Quick answers about Zenas BioPharma

Who invested in Zenas BioPharma?

Zenas BioPharma's investors include New Enterprise Associates, Norwest Venture Partners, Wellington Management, Vivo Capital and SR One, and 11 more on record.

How much has Zenas BioPharma raised?

Zenas BioPharma has raised $420M across 3 rounds since 2024.

When did Zenas BioPharma last raise?

Zenas BioPharma's most recent round was an Undisclosed round of $100M in Mar 2026.

What was Zenas BioPharma's biggest round?

Zenas BioPharma's largest round on record is $200M (Series C), in May 2024, led by New Enterprise Associates.

Who backed Zenas BioPharma first?

Zenas BioPharma's first round on record, in May 2024, was backed by New Enterprise Associates, Norwest Venture Partners and SR One and 12 others.

What stage is Zenas BioPharma at?

Zenas BioPharma's latest named round is an Undisclosed round, in Mar 2026.

Where is Zenas BioPharma based?

Zenas BioPharma is based in the United States.

Who led Zenas BioPharma's rounds?

New Enterprise Associates led the Series C in 2024.

Companies like Zenas BioPharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.